General MedicationsORALGeneric

PROPANTHELINE BROMIDE

Standard Dose

7.5MG

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview PROPANTHELINE BROMIDE is listed in Drugs@FDA under application 080927 (ANDA).

Marketing status: Discontinued Active ingredient PROPANTHELINE BROMIDE Form and strength TABLET;ORAL - 7.5MG Sponsor HIKMA Submission history Latest submission status date: 2000-02-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROPANTHELINE BROMIDE is listed in Drugs@FDA under application 080927 (ANDA). Marketing status: Discontinued Active ingredient PROPANTHELINE BROMIDE Form and strength TABLET;ORAL - 7.5MG Sponsor HIKMA Submission history Latest submission status date: 2000-02-07 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.